It also addresses the FDA’s communications Together with the applicant, the retention of records that assist the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer possession of an SE report back to a whole new applicant and electronic submission with the SE repo